Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
Trial ID or NCT#
The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.
Confounder-Corrected Quantitative Magnetic Resonance Imaging (MRI) Biomarker of Hepatic Iron Content
- - know or suspected iron overload - minimum age: Stanford- 8years , University of Wisconsin - 10 years, John Hopkins follow- 10 years, University of Texas-Southwestern - 18 years
- - contraindication to magnetic resonance imaging
Contact us to find out if this trial is right for you.
Elisabeth Merkel, RN
View on ClinicalTrials.gov